Valuation: CardioGenics Holdings Inc

Market Cap 382K 335K 310K 285K 537K 36.85M 546K 3.7M 1.45M 18.03M 1.44M 1.4M 62.13M P/E 2014
-2.3x
P/E 2015 -2.17x
Enterprise Value 539K 472K 436K 401K 757K 51.95M 770K 5.22M 2.05M 25.42M 2.02M 1.98M 87.57M EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
97.49%
Yield 2014 *
-
Yield 2015 -
3 months-99.00%
6 months-99.00%
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0.11
10 years 0
Extreme 0
0.29
Manager TitleAgeSince
Chief Executive Officer 68 27/10/2009
Director of Finance/CFO 78 16/06/2010
Investor Relations Contact 65 -
Director TitleAgeSince
Chairman 76 16/06/2010
Director/Board Member 68 06/04/2011
Director/Board Member 65 16/06/2010
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-99.00%-99.00%-99.00% 142
-5.00%-5.04%+229.56%+303.14% 20.67B
-1.10%+3.44%-39.02%-23.29% 9.85B
-2.96%+1.15%+48.97%+25.52% 7B
-1.19%+3.84%+275.87%-25.85% 5.55B
+3.43%+7.18%-14.36%-20.83% 5.23B
-8.46%+23.30%+84.85%+105.62% 4.9B
-5.64%-6.04%-43.34% - 4.66B
+1.27%+2.01%-22.43%-25.26% 4.2B
+1.21%+5.98%-14.81%-39.11% 2.72B
Average -1.19%-7.28%+40.63%+22.33% 6.48B
Weighted average by Cap. -1.89%+1.02%+96.29%+104.22%

Financials

2014 2015
Net sales - -
Net income -2.68M -2.35M -2.17M -2M -3.77M -258M -3.83M -25.96M -10.18M -126M -10.06M -9.84M -436M -1.92M -1.68M -1.55M -1.43M -2.69M -185M -2.74M -18.56M -7.28M -90.42M -7.2M -7.04M -312M
Net Debt 132K 116K 107K 98.54K 186K 12.75M 189K 1.28M 502K 6.24M 497K 486K 21.5M 157K 137K 127K 117K 220K 15.09M 224K 1.52M 594K 7.38M 588K 575K 25.44M
Logo CardioGenics Holdings Inc
CardioGenics Holdings Inc. is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. The Company has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.
Employees
4
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. CGNH Stock